跳至主要内容
临床试验/CTRI/2025/05/086448
CTRI/2025/05/086448尚未招募4 期

A single-arm open-labelled clinical study to evaluate the efficacy of guduchi siddhaksheer ghrut basti in katisandhigata vata w.s.r. to lumbar spondylosis.

Dr. Pratiksha Jaishankar Tripathi1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2025年5月17日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
45
试验地点
1
主要终点
Katishoola

研究概览

简要总结

Nowadays humans are suffering from many lifestyle-related disorders due to the adaption of modern

lifestyle. Katisandhigata vata is one of them. It is not only clinical but also social, economic & public health

problems affecting the general population indiscriminately. It is not a life-threatening condition, but it

causes great discomfort and restriction in social and other activities [3]. 25% of females are prone to

Sandhigata Vata where whereas 16% of males are affected due to it. Conventional treatments, including

pharmacological interventions and physical therapy, often provide limited relief and may be associated with

side effects. Guduchi siddhaksheer ghrut basti, an ayurvedic therapeutic procedure involves the

administration of medicated Ksheerbasti prepared with guduchi. This study aims to evaluate the

effectiveness of guduchi siddhaksheer ghrut basti in managing symptoms of lumbar spondylosis, potentially

offering a holistic and safer alternative to conventional treatment.

研究设计

研究类型
Interventional
分配方式
Random Number Table
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Patients having classical signs and symptoms of Katisandhigata Vata.
  • •(Niraam avastha) a.
  • •Katishoola (pain in low back) b.
  • •Katistambha (stiffness of lower back) c.
  • •Akunchana Prasarana Pravrutti Savedana (painful joint movements) Patients aged between 18 and 60 years and all genders.
  • •Diagnosed with lumbar spondylosis based on clinical and radiological finding.
  • •Willingness to participate and provide informed consent.

排除标准

  • •Patients with acute lumbar spine injuries or fractures.
  • •Presence of systemic diseases such as diabetes, rheumatoid arthritis, CA, or any major autoimmune disorder Pregnant or lactating women.
  • •Patients not willing to consent.
  • •Patient not eligible for basti karma.

结局指标

主要结局

Katishoola

时间窗: 14 days

次要结局

  • Katistambha(Akunchana Prasarana Pravrutti Savedana)

研究者

发起方
Dr. Pratiksha Jaishankar Tripathi
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验